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Abstract
Background: Toll-like receptors (TLRs) as pattern recognition receptors, participate in both innate and adaptive immune
responses, and seem to play an important role in the pathogenesis of asthma. This study aimed to identify key TLRs
involved in antigen induced pulmonary inflammation (AIPI), a rat model for asthma, and to explore the role of TLRs in the
disease development.
Methods and Findings: E3 rats were sensitized with ovalbumin (OVA)/alum intraperitoneally and intranasally challenged
with OVA to induce AIPI model. TLR1-9 and cytokine mRNA expression in spleen, lung and mediastinal lymph node (mLN)
tissues were screened by quantitative real-time polymerase chain reaction. TLR7 expression was found to be significantly
down-regulated in spleen while TLR3 and TLR8 expression was up-regulated in mLN of AIPI rats. Furthermore, imiquimod (a
ligand of TLR7) and TLR3 specific short-hairpin RNA plasmid for RNA interference were administrated, respectively, in vivo to
AIPI rats to observe their effects on the disease by assessing various asthmatic parameters. The numbers of total cells,
eosinophils, macrophages and lymphocytes were counted according to differential morphology in bronchoalveolar lavage
fluid. Serum IgE and OVA specific IgG1 concentration was detected by enzyme-linked immunosorbent assay. The results
showed that both TLR7 ligand treatment and TLR3 RNAi in vivo decreased serum IgE level and interleukin-4 mRNA
expression.
Conclusion/Significance: TLR3 in mLN and TLR7 in spleen both systemically modulate disease development in AIPI rats via
altering serum IgE concentration relevant to Th2 responses. And these findings may provide an important clue for further
research in the asthma pathogenesis and suggest a new remedy for asthma treatment.
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Introduction
Asthma with a high mobidity is an inflammatory disease of the
lower airways. It is widely accepted that Th2 cells are critical
regulators of asthma pathogenesis [1,2]. Th2 cells secrete
inflammatory cytokines, such as interleukin-4 (IL-4), and
interleukin-5, which play key roles in the development of asthma
[3]. However, the pathogenesis of asthma is so complex that it is
still not fully understood up to now. Recently many researchers
focus on toll-like receptors (TLRs) which have been considered to
be important factors in the development of asthma. TLRs, which
play a crucial role in both innate and adaptive immune response,
can recognize pathogen-associated molecular patterns and their
activation can induce the production of proinflammatory
cytokines [4]. TLRs are widely expressed in the cells of the
respiratory system, such as airway epithelial cells, airway smooth
muscle cells, mast cells, fibroblasts and tracheal smooth muscle
cells [5].
Association studies in asthma patients have demonstrated that
the close relations between gene polymorphisms of TLRs and
asthma [6–10]. Besides, animal models have been used to explore
the roles of TLRs in asthma. TLR2 is reported to play a pro-
allergic role in the allergic host, and stimulation of TLR2 ligand
augments Th2 responses and exacerbates airway hyperrespon-
siveness (AHR) [11–13]. However, it is also reported that a
synthetic TLR2 ligand reduces eosinophil count in the broncho-
alveolar lavage fluid (BALF), AHR as well as serum IgE level [14].
dsRNA triggers the exacerbation of the pulmonary allergic
reaction through TLR3/TRIF-dependent pathway [15]. Interest-
ingly, it has been found that both low and high doses of poly(I:C)
could induce pulmonary inflammation, and lung inflammation
enhanced by low-dose dsRNA depended on Th2 immune
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depended on Th1 immune response [16]. Although the role of
TLR4 in asthma development is controversial, growing evidence
proves that high levels of LPS exert beneficial effect in asthma
models due to the induction of a Th1 response while low dose of
LPS biases the immune response toward a Th2 phenotype and
results in aggravation of experimental asthma [17,18]. Some
researchers have demonstrated that synthetic TLR7 ligands can
inhibit Th2 responses, airway remodeling and attenuate airway
inflammation in mouse asthma models [19–21]. TLR9 activation
can down-regulate allergic responses by promoting Th1 cytokine
generation and synthetic TLR9 agonists have been developed as
new drugs to treat asthma [22].
Although there have already been lots of studies implying the
role of TLRs in asthma, few studies have characterized the
expression profile of TLRs in the animal asthma model, and the
roles of TLRs are still controversial and obscure. So in the present
study we constructed antigen induced pulmonary inflammation
(AIPI) model in E3 rats and tried to identify the key TLRs in the
disease development by detecting TLR1-9 expression in spleen,
lymph nodes and lung. The results indicated TLR3 in spleen was
up-regulated while TLR7 in mediastinal lymph node (mLN) was
down-regulated in AIPI model. And intervention of TLR3 and
TLR7 by RNA interference (RNAi) or ligand stimulation
influenced IgE production and IL-4 expression. All these findings
illustrate that TLR3 and TLR7 in immune organs play a vital role
in the development of asthma.
Results
TLR3, TLR7 and TLR8 mRNA expression was regulated in
immune organs of E3 rats in AIPI model
To investigate the role of TLRs in asthma development, we
constructed AIPI model by using ovalbumin (OVA) to sensitize and
challenge E3 rats and detected TLR1-9 mRNA expression in
spleen, mLN and lung of the rats by using quantitative real-time
polymerase chain reaction (PCR). Various asthmatic parameters
were assessed to confirm the success of the model adopted in the
presentstudy [23]. TLR7 transcripts in spleen tissues from AIPI rats
were significantly reduced compared with control rats, and no
significant difference in other TLR mRNA expression levels was
detected (Figure 1A). Besides, we examined the expression of
relative cytokines in spleen tissues by QPCR (Figure 1B and C).
Significantly elevated levels of IL-4 (P,0.001) and interleukin-6 (IL-
6) (P,0.01) mRNA expression were observed in the AIPI rats.
However, OVA treatment did not change the levels of transforming
growth factors-b (TGF-b) mRNA expression in the spleen tissues.
In addition, we also measured TLR1-9 and cytokine mRNA
expression in mLN tissues from AIPI and control (Figure 2). Using
QPCR, we observed that AIPI rats expressed higher TLR3 and
TLR8 mRNA compared to control group (Figure 2A). And
outstandingly, interleukin-12p35 transcripts were decreased in the
mLN tissues of AIPI rats (Figure 2B).
After investigating TLR1-9 mRNA expression in the lung
tissues, we did not found any significant difference of TLR mRNA
expression level in the lungs between AIPI and control groups
(Figure 3A). And cytokine mRNA expression showed that IL-4
(P,0.001) and TGF-b transcripts were significantly increased in
the lung tissues from AIPI rats (Figure 3C).
TLR7 agonist administration has marked effect on AIPI via
influencing serum IgE level
To further determine the role of down-regulated TLR7 on
asthma development, we investigated whether TLR7 agonist could
affect AIPI development. E3 rats were treated with vehicle or
imiquimod at indicated time points during AIPI induction,
respectively. And various asthmatic parameters were assessed.
First we detected TLR7, IL-4, IL-6 and interferon-a (IFN-a)
mRNA expression in spleen using QPCR. TLR7 and IFN-a
transcripts in spleen tissues were significantly increased after the
treatment with imiquimod, while IL-4 mRNA level was markedly
decreased (Figure 4A). Furthermore, it was obviously showed that
a significant difference was detected in the level of IgE production
between groups treated with vehicle and imiquimod (Figure 4B).
But imiquimod did not influence OVA-specific IgG1 release
(Figure 4B and C). Statistical analysis of cell number counted in
BALF (Figure 4D) showed that imiquimod administration only
influenced lymphocyte recruitment to the lung. The numbers of
total cells, eosinophils and macrophages were unaffected. Taken
together, these findings demonstrated that TLR7 agonist mainly
influenced serum IgE release and hardly affected other asthmatic
parameters.
TLR3 RNAi in vivo attenuated AIPI through suppressing
IgE release
To confirm that up-regulated TLR3 played an important part in
asthma development, we interfered TLR3 expression with specific
short-hairpin RNA (shRNA) plasmid. The rats were intranasally
instilled with saline, shRNA-nc plasmids or shRNA-TLR3 plasmids
at indicated time points during AIPI induction, accordingly. And
various asthmatic parameters were assessed. We first examined
TLR3 mRNA expression in rats to evaluate the efficiency of RNA
interference. TLR3 mRNA level in mLN of AIPI+sR-TLR3 group
was significantly lower than that of AIPI group (P,0.05), which
demonstrated the interfering effect of shRNA on TLR3 mRNA
expression (Figure 5A). Besides, we noticed that shRNA-TLR3
plasmid administration considerably down-regulated IL-4 and IL-6
mRNA expression in mLN tissues (Figure 5A). Serum IgE level was
markedly lower in AIPI+sR-TLR3 group, compared to AIPI group
and AIPI+sR-nc group (Figure 5B). Additionally, TLR3 RNAi also
significantly inhibited OVA-specific IgG1 release compared to
shRNA-nc plasmids administration (Figure 5C). Furthermore, we
counted total cell, eosinophil, macrophage and lymphocyte number
in BALF. However, no significant difference was detected among
the three groups (Figure 5D). Taken together, these data suggested
that administration of TLR3 RNAi to AIPI rats influenced some
parameters andalternation ofserum IgE level was themost obvious.
Discussion
Allergic asthma is considered to be an immune disease, in which
Th2 cells are critical regulators. TLRs play a vital role in T cell
polarization while spleen and lymphonodes are main lymphatic
organs in which Th0 cells differentiate to Th1 or Th2 cells.
Therefore the present study focuses on TLRs in spleen and mLN,
the main draining lymphonode of lung and bronchus, related with
asthma. With the limitation to collect patients’ material, most
researches elucidating the relationship between TLRs and asthma
have been conducted with asthma animal models [24–27]. Thus in
the present study, we adopted AIPI model to explore the
expression profile of TLRs and evaluate TLR expression
regulation in spleen, mLN and lung.
The AIPI model is established with E3 rats, an inbred rat which
is susceptible to asthma but resistant to Th1 type diseases. The
model shows more similar phenotypes to human asthma by
histological and biochemical estimation compared to other rat
strains [23,28–31]. By assaying QPCR, we screened the TLR
expression and found that TLR7 expression was significantly
The Roles of TLRs in Asthma Development
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17252down-regulated in spleen while TLR3 and TLR8 expression was
up-regulated in mLN in AIPI rats. Although TLRs are expressed
on numerous types of cells in respiratory system, in the present
study TLR mRNA expression in lung did not show difference in
two groups while IL-4 and TGF-b expression increased signifi-
cantly in AIPI rats. While researchers mainly focus on TLRs in
lung and airway, the present results lead us to pay more attention
to the TLRs in immune organs, such as spleen and mLN, which
may play a crucial role in the pathogenesis of asthma. So next we
investigated the role of TLR7 in spleen and TLR3 in mLN on the
disease development further.
Down-regulated TLR7 expression in spleen may reflect a
systemic immune regulation of AIPI rats. In fact, several studies
have reported that TLR7 agonists could attenuate the symptom of
experimental asthma and virus-induced airway dysfunction [19].
And a recent study has showed that imiquimod significantly
inhibits chronic inflammation, persistent AHR and airway
remodeling in chronic experimental asthma [20]. Activation of
TLR7 can initiate a very strong Th1 response through inducing
NF-kB signaling. This effect might be performed by modulating
key master switches GATA-3 and T-bet that results in committing
T helper cells to a Th1 phenotype [32]. After imiquimod
intraperitoneal injection to AIPI rats, TLR7 mRNA and IFN-a
mRNA levels both elevate in the spleen tissues while IL-4 mRNA
level decreases, which is consistent with the effect of imiquimod in
anticipation. Previous studies showed that imiquimod application
could reduce IL-4 in BALF and serum [20,32]. And it was found
that resiquimod treatment would result in the decrease of Th2
Figure 1. TLR and cytokine mRNA expression in spleen of rats from control group and AIPI group. TLR1-9 mRNA expression (A), IFN-a,
IFN-b, IL-1b, IL-12p35, IFN-c mRNA expression (B) and IL-4, TGF-b, IL-6 mRNA expression (C) were measured by QPCR. The rats in AIPI group were
sensitized and challenged with OVA, while the rats of control group was administrated PBS. Results show as mean 6SEM from 10 rats in each group.
*P,0.05, **P,0.01 and ***P,0.001; significantly different from control group.
doi:10.1371/journal.pone.0017252.g001
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lung of mice or rat model [33–35]. Our present results indicated
that notably in spleen, the central peripheral immune organ, the
induction of TLR7 also inhibited the production of Th2 cytokines.
Furthermore, in our results, imiquimod also modulated IgE
production just as previous studies showed [20,33,35,36].
Decreased IgE has been shown in isolated human B cells and
allergic human B cells treated with resiquimod [37,38]. IgE is a
characteristic biomarker of asthma patients. The allergen-
activated Th2 cells produce IL-4, which stimulates B cells to
undergo heavy-chain class switching from IgM to IgE [3,39].
Hence TLR7 in spleen may play a key role in the development of
asthma via IL-4 to induce the production of allergen-specific IgE
by B cells. However, in our model imiquimod failed to further alter
other asthmatic parameters, such as eosinophils number in BALF,
which was opposite to other studies before [32,33,35]. These
findings suggest that spleen TLR7 is involved into only an aspect
of the pathogenesis of AIPI and mainly affect systemic immune
response just like IgE level. Furthermore, it was found that
imiquimod could interact with adenosine receptor as an
antagonist, and appeared to suppress the cAMP production and
subsequently induce the proinflammatory cytokines via activating
the NF-kB pathway [40]. In the present study, imiquimod
increased the IFN-a expression in the spleen of AIPI rats which
Figure 2. TLR and cytokine mRNA expression in mLN of rats from control group and AIPI group. TLR1-9 mRNA expression (A), IFN-a, IFN-
b, IL-1b, IL-12p35, IFN-c mRNA expression (B) and IL-4, TGF-b, IL-6 mRNA expression (C) were measured by QPCR. The rats in AIPI group were
sensitized and challenged with OVA, while the rats of control group was administrated PBS. Results show as mean 6SEM from 10 rats in each group.
*P,0.05; significantly different from control group.
doi:10.1371/journal.pone.0017252.g002
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TLR7 signaling. So we believe that imiquimod might play its role
mainly by TLR7 signaling pathway, although we still could not
rule out the involvement of the adenosine receptors by now.
Up-regulated TLR3 expression in mLN, the draining lympho-
node of lung tissue may reflect a local immune response of AIPI
rats. It is reported that Rhinoviruses, a major etiology of the
common cold, could increase the expression of TLR3 on the
human bronchial epithelial cells, and trigger exacerbation of the
pulmonary allergic reaction through TLR3/TRIF-dependent or
TLR3/IRF3-dependent pathway [15,41,42]. Such studies imply
that TLR3 may play a critical role in asthma. Nevertheless, a
recent study has been reported that application of TLR2, TLR3,
TLR4 and TLR7 agonists all show a protective effect for asthma
[43]. And TLR3-induced IL-6 is similar in asthmatic and control
subjects while TLR7 function is reduced in adolescents [44].
However, long-term activation of TLR3 induces inflammation
and impaired lung function in mice [45]. Therefore the role of
TLR3 in asthma is still obscure for researchers. Based on the up-
regulation of TLR3 mRNA level in mLN of AIPI rats, we
knockdowned TLR3 expression of AIPI rats through in vivo RNAi.
Jeon et al. found that AHR enhanced by low or high doses of
poly(I:C) did not develop in TLR3-deficient mice, while OVA-
specific IgE production enhanced by low-dose poly(I:C) and serum
OVA-specific IgG2a levels enhanced by high-dose poly(I:C) also
did not develop in TLR3-deficient mice [16]. The lung
inflammation were induced both by low-dose and high-dose
poly(I:C), but the former played its role by Th2 immune response
and the latter by Th1 response [16]. In the present study IL-4
mRNA in mLN, IgE and IgG1 levels in serum were reduced by
TLR3 RNAi systemically. It might hint us that TLR3 may exert it
function by Th2 immune response, but Th1 response could not be
excluded. Furthermore, TLR3-shRNA did not alter total cell
number and macrophage in BALF as that shown in other studies,
Figure 3. TLR and cytokine mRNA expression in lung of rats from control group and AIPI group. TLR1-9mRNAexpression(A),IFN-a,IF N - b,
IL-1b, IL-12p35 mRNA expression (B) and IL-4, TGF-b, IL-6 mRNA expression (C) were measured by QPCR. The rats in AIPI group were sensitized and
challenged with OVA, while the rats of control group was administrated PBS. Results show as mean 6SEM from 10 rats in each group. *P,0.05;
***P,0.001; significantly different from control group.
doi:10.1371/journal.pone.0017252.g003
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investigation further. Moreover, the effect of TLR3 knockdown
suggests the roles of an endogenous TLR3 ligand or constitutive
TLR3 activity in AIPI rats, which should be paid more attention
to in further study.
In conclusion, TLR3 and TLR7 levels were not modulated in
the lung following AIPI, but TLR7 was down-regulated in spleen,
while TLR3 was up-regulated in draining lymph nodes. Down-
regulation of TLR3 expression and activation of TLR7 both
caused decrease of serum IgE level and reduction of IL-4 mRNA
expression in immune organs from AIPI rats. The results present
in this study suggested that TLR3 and TLR7 in immune organs
both systemically modulated disease development in AIPI rats by
reducing serum IgE release via IL-4 down-regulation, and which
Figure 4. Assessment of various asthmatic parameters in TLR7 agonist stimulated AIPI rats. E3 rats were injected intraperitoneally with
vehicle or TLR7 agonist on day 13 and 17 during the period of AIPI induction. The rats of AIPI group (n=9) received 1 ml saline and the rats of
AIPI+imi (imiquimod) group (n=9) received 100 mg miquimod. TLR7 mRNA and cytokine mRNA expression levels in spleen were measured by QPCR
(A). Levels of serum total IgE (B) and OVA-specific IgG1 (C) were measured by ELISA. Total cell numbers in BALF were counted under light microscope
using a hemocytometer and values of macrophage, eosinophil and lymphocyte counts in BALF were expressed as the percentage of cell numbers of
total cells (D). Results show as mean 6SEM from 9 rats in each group. *P,0.05; **P,0.01; ***P,0.001; significantly different from AIPI group.
doi:10.1371/journal.pone.0017252.g004
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PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17252Figure 5. Assessment of various asthmatic parameters in TLR3 RNAi AIPI model. E3 rats were intranasally instilled with either saline or plasmids on
day 13 and 17 during the period of AIPI induction. The rats of AIPI group (n=9) received 50 ml saline, the rats of AIPI+sR-nc (n=9) group received 50 mgs h R N A -
nc plasmid and the rats of AIPI+sR-TLR3 group (n=9) received 50 mg shRNA-TLR3 plasmid. TLR3 mRNA and cytokine mRNA expression levels in mLN were
measured by QPCR (A). Levels of serum total IgE (B) and OVA-specific IgG1 (C) were measured by ELISA. Total cell numbers in BALF were counted under light
microscope using a hemocytometer and values of macrophage, eosinophil and lymphocyte counts in BALF were expressed as the percentage of cell numbers
of total cells (D). Results show as mean 6SEM from 9 rats in each group. *P,0.05 or **P,0.01 or ***P,0.001 denotes significance between two groups.
doi:10.1371/journal.pone.0017252.g005
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pathogenesis and suggest a new target for asthma treatment.
Materials and Methods
Rats
E3 rats were maintained in a specific-pathogen free facility of
Xi’an Jiaotong University School of Medicine. Animal study
protocols were approved by the Institutional Animal Ethics
Committee of Xi’an Jiaotong University (permission No. 2009-12).
Induction of AIPI model with ovalbumin
Induction of AIPI was performed as follows: the rats were
sensitized on day 0 by intraperitoneal injection of 1 mg of OVA
(Sigma-Aldrich, St. Louis, MO, USA) emulsified in 50 mg Alum
(Sigma-Aldrich, St. Louis, MO, USA) ina total volume of 1 ml PBS;
on day 14 the rats were subjected to intranasal challenge of 100 ml
OVA/PBS(1 mg/ml)once daily for 7 days, while control group was
administrated only PBS for sensitization and challenge (Figure 6A).
TLR7 agonist stimulation
Eighteen E3 rats, 8–12 weeks of age were randomly distributed
into 2 groups that received intraperitoneal injection on day 13 and
17 during the period of AIPI induction as follows: 1 ml saline,
served as AIPI group; 100 mg of imiquimod, a TLR7 agonist
(Merck, Darmstadt, Germany) in 1 ml saline, named as AIPI+i-
miquimod group. On day 21 rats were sacrificed and various
parameters were measured (Figure 6B).
TLR3 RNA interference in vivo
The target sequence of TLR3 gene for RNAi is ACC TCG
ACC TCA CAG AGA A, and the negative control sequence is
TTC TCC GAA CGT GTC ACG T [46]. These different
shRNA sequences were inserted into pGCsilencer
TM U6/Neo/
Figure 6. Schematic diagrams of the induction of rat models. Schematic diagrams showed the induction of AIPI (A), TLR7 ligand stimulation
(B) and in vivo TLR3 RNAi (C) in E3 rats.
doi:10.1371/journal.pone.0017252.g006
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E3 rats aged 8–12 weeks old were intranasally instilled with either
saline or plasmids on day 13 and 17 during the period of AIPI
induction. The rats were randomly divided into 3 groups: 50 ml
saline, served as AIPI group; 50 mg of shRNA-TLR3 plasmid in
50 ml saline, named as AIPI+sR-TLR3 group; and 50 mgo f
shRNA-nc plasmid in 50 ml saline, named as AIPI+sR-nc group
(Figure 6C). Rats were sacrificed on day 21 and various
parameters were measured.
Cell count in BALF
Soon after the lung was removed, BALF was collected via
cannulation of the exposed trachea and gentle flushing of the lungs
with 2 ml of PBS for three times (total 6 ml). Total cell numbers
were counted under light microscope by using a hemocytometer.
To count the number of macrophages, eosinophils and lympho-
cytes in BALF, cytocentrifuged preparations were fixed on slide
and stained with Wright-Giemsa differential staining. The number
of differential cells were counted according to differentiated
morphology and expressed as a percentage of total cells.
ELISA for rat immunoglobulin concentration
measurement
Total IgE and OVA-specific IgG1 concentration in the serum of
rats was measured by enzyme-linked immunosorbent assay
methods. Briefly, 50 ml of polyclonal anti-IgE antibody (AbD
Serotec, Munich, UK) or OVA diluted in NaHCO3 buffer was
transferred to enzyme-linked immunosorbent assay plates and
Table 1. Primer sequences used for QPCR
Name Type Sequence (59-39) Expected length (bp) Optimal annealing temperature (6C)
TLR1 Forward CAGCAGCCTCAAGCATGTCTA 82 60
Reverse CAGCCCTAAGACAACAATACAATAGAAGA
TLR2 Forward CTCCTGTGAACTCCTGTCCTT 74 60
Reverse AGCTGTCTGGCCAGTCAAC
TLR3 Forward GATTGGCAAGTTATTCGTC 205 54
Reverse GCGGAGGCTGTTGTAGG
TLR4 Forward GATTGCTCAGACATGGCAGTTTC 135 54
Reverse CACTCGAGGTAGGTGTTTCTGCTAA
TLR5 Forward GGGCAGCAGAAAGACGGTAT 61 60
Reverse CAGGCACCAGCCATCCTTAA
TLR6 Forward GGAGCCTTCAGTAGCCTTTC 115 60
Reverse GGTTGTTCCCCGCTGTTAT
TLR7 Forward GTTTTACGTCTACACAGTAACTCTCTTCA 75 60
Reverse TTCCTGGAGGTTGCTCATGTTTT
TLR8 Forward GGGGTAACACACCGTCTA 150 60
Reverse GTCAAGGCGATTTCCACT
TLR9 Forward CCGAAGACCTAGCCAACCT 70 60
Reverse TGATCACAGCGACGGCAATT
IFN-a Forward GCAACCCTCCTAGACTCATTCTG 83 65
Reverse ACCCCTACCTGCTGCATCAG
IFN-b Forward CTTGGGTGACATCCACGACTAC 92 60
Reverse GGCATAGCTGTTGTACTTCTTGTCTT
IFN-c Forward AGAGCCTCCTCTTGGATATCT 309 65
Reverse GCTTCCTTAGGCTAGATTCTGGTG
IL-1b Forward CTGTGACTCGTGGGATGATGAC 322 53
Reverse CTTCTTCTTTGGGTATTGTTTGG
IL-12p35 Forward AAGACATCACACGGGACAAA 300 60
Reverse GATTCAGAGACCGCATTAGC
IL-6 Forward AAGAAAGACAAAGCCAGAGTC 263 57
Reverse CACAAACTGATATGCTTAGGC
IL-4 Forward TGCACCGAGATGTTTGTACCAGA 92 63
Reverse TTGCGAAGCACCCTGGAAG
TGF-b Forward GGACTACTACGCCAAAGAAG 294 57
Reverse TCAAAAGACAGCCACTCAGG
GAPDH Forward CGGCAAGTTCAACGGCACAG 148 60
Reverse GAAGACGCCAGTAGACTCCACGAC
doi:10.1371/journal.pone.0017252.t001
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with 250 ml washing buffer (PBS containing 0.05% Tween-20) and
blocked with blocking solution (2% BSA in washing buffer) for 1 h
at 37uC. Rat serum diluted 100 times was added and the plates
were incubated for 1 h at 37uC. Then horseradish peroxidase-
conjugated mouse anti-rat kappa/Lambda chain (1 mg/ml)
antibody (AbD Serotec, Munich, UK) was added to detect IgE
and IgG1. A mixture of H2O2 and tetramethylbenzidine was used
as a substrate. The reaction was stopped by 2 M H2SO4 and
absorbance was measured at 450 nm.
RNA isolation and real-time quantitative RT-PCR
Total RNA was isolated respectively from spleen, mediastial
lymph nodes (mLN) and lung by using TRIzol (Invitrogen Life
Technology, Carlsbad, CA, USA). cDNA was synthesized from
5 mg of total RNA by utilizing a reverse transcription kit
(RevertAid
TM, Fermentas Life Science, International INC,
Canada) in a final volume of 20 ml. QPCR was then performed
using SYBRH Premix Ex Taq
TM II (TaKaRa, Japan) in iQ5 real-
time PCR detection system (Bio-Rad, CA, USA). The following
program was used: pre-denaturation at 95uC for 30 s and 40
cycles consisting of denaturation at 95uC for 5 s, annealing at 53–
65uC for 20 s, and extension at 72uC for 15 s. The specificity of
the amplified PCR products was assessed by a melting curve
analysis. The primer sequences for TLRs and cytokines can be
found in Table 1. Relative quantitation of gene expression was
normalized to GAPDH.
Statistical analysis
All data were expressed as mean 6 standard error (SEM).
Mann-Whitney U test and Krusckal-Wallis H test were performed
to test statistically significant differences by using SPSS 13.0 (SPSS
software, Chicago, IL, USA) for the type of data without normal
distribution or homogeneity of variance. A P value of less than
0.05 was considered significant.
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